Pr Eric E. GabisonCornea and ocular surface · Paris
FR EN
HomeCorneal wound healing › Physiology
ToolOcular toxicity of ADCs — molecule fact sheets — 22 antibody-drug conjugates grouped by cytotoxic payload: reported ocular effects, prophylaxis, monitoring, treatment and chemotherapy modulation.Open → New New course: Ocular toxicity of antibody-drug conjugates — on-target and off-target pathophysiology, microcyst-like epithelial keratopathy, limbal stem cell deficiency, CTCAE grading and ADC-specific management. Open → New New course : Topical NSAIDs & corneal healing — keratolysis, refutation of the excipient hypothesis, the COX pathway and 12-HHT/BLT2, the EMMPRIN/CD147 axis, at-risk patients and practical management. Explore → New New sub-chapter: corneal macrophages — response timeline, M1/M2 polarization, NLRP3, MIF, TGF-β (after Yaghmour et al., Life 2026). Discover →
Course contents ▾
  1. Introduction & aims
  2. Epithelial healing
  3. Stromal healing
  4. Delayed healing & PED
  5. Corneal fibrosis (haze)
  6. Ulceration & CD147/MMP
  7. Angiogenic privilege
  8. Corneal neovascularization
  9. Summary & key points
  10. Summary table
  11. References
Chapter 1 of 4

Corneal wound healing

Authors: Pr Éric Gabison, M. Cavaillé and C. Tolosa Leal — ophthalmology, cornea & ocular surface. Reference course, original synthesis (2026), grounded in the team's own work.

Introduction & aims

Corneal wound healing closes the wound without compromising transparency or the avascularity of the tissue, which sets it apart from skin repair [1,2].

An injury may involve the epithelium alone, the epithelium + stroma, and more rarely the endothelium (whose regenerative capacity in humans is very limited). The healing response must restore the epithelial barrier, rebuild the stroma and preserve optical clarity, while avoiding three pitfalls: fibrosis (opacity), delayed healing (ulceration, melting) and neovascularization.

The thread of this course is a permanent epithelial–stromal dialogue: it steers repair toward transparent regeneration or toward fibrosis. We follow the physiology (epithelial then stromal repair), the pathological situations (persistent epithelial defect, haze, ulceration and direct epithelial–stromal interactions), then the corneal angiogenic privilege and its breakdown.

Guiding thread

Repairing the cornea means winning three bets at once: fast, transparent, vessel-free. The key to the outcome is when the epithelium and its basement membrane reform: while they remain open, stromal signals (TGF-β, PDGF, MMPs) sustain fibrosis and melting [2,3].

Epithelial healing & the barrier

The first step after an epithelial injury is the removal of necrotic cells, aided by the tear film and blinking. Within minutes, edge cells form a migration front and move centripetally at about 60–80 µm/h. The classic kinetics combine a sliding phase (migration, no mitosis) then a proliferation phase restoring epithelial thickness [2,10].

Mechanics of migration

To advance, cells disassemble their hemidesmosomes (integrin α6β4) via metalloproteinases, anchor to the stroma through focal adhesions mediated by integrins (α5β1 for fibronectin), while actin cables linked by adherens junctions drive collective migration. They rely on a provisional matrix rich in fibrin, fibronectin and hyaluronic acid, and on growth-factor flux (EGF, HGF, KGF) partly derived from the underlying stroma — the first illustration of epithelial–stromal coupling [2,4].

Basement membrane: the conductor

Once the basal layer is restored, a new epithelial basement membrane (EBM) is synthesized (laminins 511/521, then perlecan, nidogens, collagen IV) and matures over ~6 weeks. Its reformation is more than anchorage: it regulates cytokine passage to the stroma. In Wilson's model, EBM regeneration is the true switch that ends the TGF-β/PDGF inflow and hence fibrosis [3]. Note that Bowman's layer does not regenerate, with no notable functional consequence.

Four requirements for good epithelial healing

A healthy basement membrane, adequate vitamin A, good-quality tears and a cornea that keeps its sensation: if any one of these four supports is missing, epithelial closure lags.

Barrier function & tight junctions (occludin)

Beyond healing, the epithelium forms a barrier through its apical tight junctions, of which occludin is a key component. Our work showed that the metalloproteinase inducer EMMPRIN/CD147 regulates surface occludin by modulating MMP-9 expression: an inverse correlation between EMMPRIN and occludin already exists physiologically, along epithelial differentiation (Huet et al., Am J Pathol 2011). CD147 thus emerges as a regulator of epithelial organization, not only a disease player.

Epithelial renewal & limbal stem cells

The epithelium renews continuously from limbal stem cells, following Thoft's “XYZ” scheme: basal proliferation (X), centripetal migration (Y), surface desquamation (Z). The speed of this turnover governs surface homeostasis and the fate of the epithelium after transplantation.

Our work quantified this turnover. Combining corneal impression cytology with FISH on sex-mismatched grafts lets one trace the origin — donor or recipient — of each cell. Across 24 samples (21 grafted patients), mosaicism was found in 13 cases, showing donor-derived cells at the graft centre for at least 211 days; Kaplan–Meier analysis put their median survival at 385 days — over a year (Catanese et al., IOVS 2011).

Slower renewal than expected

Contrary to the idea that recipient epithelium quickly replaces the graft, these data show prolonged survival of donor cells — thus slow renewal at the corneal centre — with topical 2% cyclosporine tending to further delay their loss (non-significant trend). Immunomodulation therefore influences post-graft epithelial homeostasis.

Stromal healing: keratocytes, cytokines & myofibroblasts

The stroma makes up most of the corneal thickness; its transparency depends on an orderly collagen array and on the quiescent phenotype of keratocytes. Its healing may be regenerative (transparent) or fibrotic (opaque), and its direction depends directly on re-epithelialization and basement-membrane reformation [3,5].

Three phases of stromal repair

A destruction phase (neutrophils, macrophages, collagenases), a synthesis phase (collagen and proteoglycan deposition by fibroblasts), then a remodeling phase that reorganizes the matrix to recover transparency.

Keratocyte apoptosis & the acellular zone

When the epithelial barrier breaks, epithelial cells release IL-1α/β which, binding neighbouring keratocytes, trigger their apoptosis (relayed by TNF-α, PAF and soluble FasL). A transient acellular zone forms: this redundancy of pro-apoptotic signals is thought to limit stromal (notably viral) invasion and to reduce the pool of future myofibroblasts [6].

From keratocyte to myofibroblast

Surviving keratocytes become fibroblasts (migrating within 24 h), proliferate, then differentiate into myofibroblasts under TGF-β (Smad pathway) and PDGF — factors normally kept away from the stroma by the basement membranes. Some myofibroblasts also arise from circulating bone-marrow fibrocytes [14]. Identified by α-SMA stress fibres, the myofibroblast is strongly contractile, lays down abundant matrix… and scatters light. In humans, maturation takes 1–4 months [5,2].

Epithelium-derived extracellular vesicles (exosomes), when they cross a damaged basement membrane, also contribute to keratocyte-to-myofibroblast conversion [11].

The key: the myofibroblast must not take hold

In normal healing, the epithelium and its basement membrane reform before myofibroblast progenitors mature. The resulting TGF-β drop restores IL-1 sensitivity: they undergo apoptosis before producing disorganized matrix. This timing allows opacity-free repair, under an MMP / TIMP balance [5,6].

Glossary of abbreviations used in this course

Scientific abbreviations and acronyms used throughout the 10 pages of this course, listed alphabetically.

95% CI
95% confidence interval
AAV
adeno-associated virus (gene-therapy viral vector)
ABCG2
ABCG2 transporter, a limbal stem-cell marker
AMT
amniotic membrane transplantation
anti-VEGF
anti-angiogenic treatment targeting VEGF
ASC
inflammasome adaptor protein (Apoptosis-associated Speck-like protein containing a CARD)
BrdU
bromodeoxyuridine, a cell-proliferation marker
CCL2
CCL2 chemokine, synonym of MCP-1; recruits circulating monocytes
CCR2
receptor for CCL2; marker of newly recruited monocytes/macrophages
CD147
cluster of differentiation 147; synonym of EMMPRIN and basigin
CD163
M2 macrophage marker; scavenger receptor for haemoglobin-haptoglobin
CD206
mannose receptor; marker of M2 polarization
CD74
cell-surface receptor for MIF
CDVA
corrected distance visual acuity
CGRP
calcitonin gene-related peptide
CTGF
connective tissue growth factor
CX3CL1
fractalkine, a chemokine involved in monocyte/macrophage recruitment
CXCR2/CXCR4
chemokine receptors, also receptors for MIF
DAMP
damage-associated molecular pattern
DESI
direct epithelial–stromal interaction
EGF
epidermal growth factor
EGFR
epidermal growth factor receptor
EMMPRIN
extracellular matrix metalloproteinase inducer; synonym of CD147
ETDRS
reference visual-acuity scale used in clinical research (Early Treatment Diabetic Retinopathy Study)
FasL
Fas ligand, an apoptosis-inducing protein
FISH
fluorescence in situ hybridisation
GAG
glycosaminoglycan(s)
GM-CSF
granulocyte-macrophage colony-stimulating factor
GVHD
graft-versus-host disease
HGF
hepatocyte growth factor
HIF-3α
hypoxia-inducible factor, 3-alpha subunit
HMGB1
high mobility group box 1, an alarmin released by injured cells (DAMP)
IFN-γ
interferon gamma
IGF-1
insulin-like growth factor 1
IL-1
interleukin-1
iNOS
inducible nitric oxide synthase
IPAS
inhibitory PAS domain protein
KGF
keratinocyte growth factor
LASIK
laser-assisted in situ keratomileusis
LogMAR
logarithmic visual-acuity scale
LOX
lysyl oxidase, a collagen cross-linking enzyme
LPS
bacterial lipopolysaccharide
M1
classically activated macrophage, pro-inflammatory profile
M2
alternatively activated macrophage, pro-resolving/reparative profile (subtypes M2a-M2d, M2eff)
MEN2B
multiple endocrine neoplasia type 2B
MerTK
receptor tyrosine kinase involved in efferocytosis
MIF
macrophage migration inhibitory factor
MRI
magnetic resonance imaging
NGF
nerve growth factor
NK
neurotrophic keratitis
NLRP3
NLRP3 inflammasome (NOD-, LRP- and pyrin domain-containing protein 3)
NO
nitric oxide
NSAID
nonsteroidal anti-inflammatory drug
PACAP
pituitary adenylate cyclase-activating polypeptide
PAF
platelet-activating factor
PAMP
pathogen-associated molecular pattern
PDGF
platelet-derived growth factor
PED
persistent epithelial defect
PEDF
pigment epithelium-derived factor
PGE₂
prostaglandin E2
PRK
photorefractive keratectomy (laser surface ablation)
pro-NGF
precursor form of NGF
RGTA
matrix-therapy ReGeneraTing Agent, e.g. Cacicol
rhNGF
recombinant human NGF (cenegermin)
ROS
reactive oxygen species
Smad
signalling proteins of the TGF-β pathway
SPK
superficial punctate keratitis
sVEGFR-1
soluble form of VEGF receptor-1 (= sFlt-1)
sVEGFR-3
soluble form of VEGF receptor-3
TGF-β
transforming growth factor beta
TIMP
tissue inhibitor of metalloproteinases
TLR
Toll-like receptor
TNF-α
tumour necrosis factor alpha
TRPV4
transient receptor potential vanilloid 4, a mechanosensitive ion channel
uPA
urokinase-type plasminogen activator
V1
ophthalmic branch of the trigeminal nerve
VEGF
vascular endothelial growth factor
VEGF-C
lymphangiogenic isoform of VEGF
VIP
vasoactive intestinal peptide
YAP/TAZ
Hippo pathway effectors, mechanosensors of matrix stiffness
α-SMA
alpha-smooth muscle actin, a myofibroblast marker